Varonis Systems Inc header image

Varonis Systems Inc

VRNS

Equity

ISIN null / Valor 22677089

NASDAQ (2026-01-16)
USD 33.52-1.30%

Varonis Systems Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Varonis Systems Inc. is a specialized technology company that focuses on cybersecurity and data protection solutions. With a history of innovation since its inception, Varonis has developed a comprehensive suite of software products aimed at safeguarding sensitive information from cyber threats and insider risks. The company's offerings encompass data security, governance, compliance, and analytics, designed to protect enterprise data across physical, virtual, and cloud environments. Under the leadership of key executives such as Rob Sobers, Sagiv Elmaleh, and Dov Lerner, Varonis has positioned itself as a leader in the cybersecurity space. Sobers, as the Chief Marketing Officer, drives the global marketing strategy and brand development, while Elmaleh, with his extensive engineering background, spearheads the technological vision and execution of Varonis' core products and services. Dov Lerner, joining as General Counsel, brings a wealth of legal expertise, particularly in corporate governance and securities laws, further strengthening the company's operational and strategic framework. Through its focused approach on data protection and cybersecurity, Varonis Systems Inc. addresses the critical needs of businesses in an increasingly digital and threat-prone landscape.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (06.01.2026):

Varonis Systems Inc — Third quarter of 2025: Varonis reported solid SaaS-driven revenue growth but a wider GAAP loss as the business shifts customers from on‑prem to cloud. Total revenue rose to $161.6M, ARR grew 18% to $718.6M and SaaS now represents ~76% of ARR, while the company trimmed guidance after weaker on‑prem renewals late in the quarter.

Revenue and product mix

Total revenues were $161.6M (Q3 2025) vs. $148.1M a year earlier. SaaS revenue rose sharply to $125.8M (from $57.8M), while term license subscriptions fell to $24.8M (from $68.8M) and maintenance/services to $10.9M (from $21.5M) as customers convert to SaaS.

Profitability (GAAP vs. non‑GAAP)

GAAP operating loss was ($35.9M) and GAAP net loss was ($29.9M), EPS (GAAP) (‑$0.26). On a non‑GAAP basis Varonis reported ~$0.2M of operating income and non‑GAAP net income of $8.4M (non‑GAAP diluted EPS ~$0.06) for the quarter.

ARR and key metrics

ARR was $718.6M at quarter end, up 18% year‑over‑year; SaaS ARR was ~76% of total ARR. Management highlighted healthy SaaS demand driven by cloud and AI initiatives.

Cash, liquidity and cash flow

Varonis held about $1.1B of cash, cash equivalents, short‑term deposits and marketable securities as of Sept. 30, 2025. Year‑to‑date cash from operations was $122.7M vs. $90.9M a year ago, and free cash flow was $111.6M vs. $88.6M a year ago.

Balance sheet and capital returns

The company announced a new $150.0M share repurchase authorization (expected over 12 months). The nine‑month cash flow statement also shows a $100.0M repurchase completed earlier in the period.

M&A and product launches

Varonis acquired SlashNext (AI‑native email security) and Cyral (database security) and launched Varonis Interceptor (email security), Next‑Gen Database Activity Monitoring (DAM) and AI identity protection for Salesforce Agentforce.

Headwinds and strategy change

Management cited lower renewals in the Federal vertical and in non‑Federal on‑prem subscriptions during the final weeks of Q3, and said it will end‑of‑life its self‑hosted solution—leading to reduced on‑prem renewal assumptions and the guidance cut.

Updated outlook

Q4 2025 guidance: revenues $165.0M–$171.0M (growth 4%–8%), non‑GAAP operating income $0–$3M, non‑GAAP diluted EPS $0.02–$0.04. Full‑year 2025 updated guidance: ARR $730M–$738M (14%–15% growth), revenues $615.2M–$621.2M (12%–13% growth), free cash flow $120M–$125M, and non‑GAAP operating loss ($8.2M)–($5.2M) with non‑GAAP diluted EPS $0.12–$0.13.

Summarized from source with an LLMView Source

Key figures

-26.9%1Y
36.2%3Y
-41.8%5Y

Performance

74.8%1Y
51.8%3Y
56.7%5Y

Volatility

Market cap

3952 M

Market cap (USD)

Daily traded volume (Shares)

1,754,302

Daily traded volume (Shares)

1 day high/low

44.55 / 43.63

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

UMT United Mobility Technology AG
UMT United Mobility Technology AG UMT United Mobility Technology AG Valor: 50098941
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.11%EUR 1.36
Tyler Technologies Inc
Tyler Technologies Inc Tyler Technologies Inc Valor: 804377
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.38%USD 440.01
PIERER Mobility AG
PIERER Mobility AG PIERER Mobility AG Valor: 41860974
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.59%CHF 15.96
Ambarella Inc
Ambarella Inc Ambarella Inc Valor: 19685074
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.39%USD 68.73
Spirent Communications PLC
Spirent Communications PLC Spirent Communications PLC Valor: 1076425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%GBP 1.99
Alibaba Group Holding Ltd
Alibaba Group Holding Ltd Alibaba Group Holding Ltd Valor: 24409862
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.24%USD 165.40
Celldex Therapeutics Inc
Celldex Therapeutics Inc Celldex Therapeutics Inc Valor: 46207289
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.16%USD 25.65
Veracyte Inc
Veracyte Inc Veracyte Inc Valor: 22423969
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.39%USD 41.57
Samsung SDI JH
Samsung SDI JH Samsung SDI JH Valor: 1073444
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.71%EUR 42.70
Cohu Inc
Cohu Inc Cohu Inc Valor: 919424
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.05%USD 28.25